RM

Russell L. Morris

TU Teikoku Pharma Usa: 9 patents #4 of 32Top 15%
BM Birch Point Medical: 6 patents #1 of 5Top 20%
DL Diametrics Medical Limited: 5 patents #2 of 22Top 10%
VT Verde Environmental Technologies: 4 patents #1 of 3Top 35%
NU Nupathe: 2 patents #5 of 14Top 40%
TI Teva Pharmaceutical Industries: 2 patents #16 of 140Top 15%
📍 Litchfield, MN: #4 of 107 inventorsTop 4%
🗺 Minnesota: #1,774 of 52,454 inventorsTop 4%
Overall (All Time): #112,557 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 1–25 of 32 patents

Patent #TitleCo-InventorsDate
11305144 Abuse potential reduction in abusable substance dosage form Carter R. Anderson 2022-04-19
10413768 Abuse potential reduction in abusable substance dosage form Carter R. Anderson 2019-09-17
10406394 Abuse potential reduction in abusable substance dosage form Carter R. Anderson 2019-09-10
10391346 Abuse potential reduction in abusable substance dosage form Carter R. Anderson 2019-08-27
9764130 Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis Carter R. Anderson, Walter L. Sembrowich, Robert E. Cohen 2017-09-19
9421356 Transdermal methods and systems for the delivery of corticosteroid compounds Carter R. Anderson, Robert E. Cohen, William V. Fowler 2016-08-23
9272137 Transdermal methods and systems for the delivery of anti-migraine compounds Carter R. Anderson, Terri Sebree 2016-03-01
8535711 Medication disposal system Carter R. Anderson 2013-09-17
8475837 Abuse potential reduction in abusable substance dosage form Carter R. Anderson 2013-07-02
8470853 Transdermal methods and systems for the delivery of anti-migraine compounds Carter R. Anderson, Terri Sebree 2013-06-25
8463373 Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis Carter R. Anderson, Walter L. Sembrowich, Robert E. Cohen 2013-06-11
8445010 Abuse potential reduction in abusable substance dosage form Carter R. Anderson 2013-05-21
8329212 Abuse potential reduction in abusable substance dosage form Carter R. Anderson 2012-12-11
8295924 Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions Carter R. Anderson, Robert E. Cohen 2012-10-23
8295923 Sacrificial electrode design and delivery species suitable for prolonged iontophoresis application periods Kathleen A. Eischen, Carter R. Anderson 2012-10-23
8239018 Dosage control electrode for iontophoresis device Carter R. Anderson 2012-08-07
7973058 Transdermal methods and systems for the delivery of anti-migraine compounds Carter R. Anderson, Terri Sebree 2011-07-05
7904146 Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions Carter R. Anderson, Robert E. Cohen 2011-03-08
7867511 Abuse potential reduction in abusable substance dosage form Carter R. Anderson 2011-01-11
7856263 Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis Carter R. Anderson, Walter L. Sembrowich, Robert E. Cohen 2010-12-21
7844327 Dosage control electrode for iontophoresis device Carter R. Anderson 2010-11-30
7031769 Dosage control electrode for iontophoresis device Carter R. Anderson 2006-04-18
7031768 Controlled dosage drug delivery Carter R. Anderson, Clayton Anderson, Walter L. Sembrowich 2006-04-18
7016723 Rate adjustable drug delivery system Carter R. Anderson 2006-03-21
6745071 Iontophoretic drug delivery system Carter R. Anderson, Clayton Anderson, Lori A. Grace 2004-06-01